Tech & Pharma
Kindstar will validate and implement ACD’s RNAscope® technology-based molecular diagnostic assays in its clinical laboratories.
Singapore’s Nanyang Technological University has launched a cryo-electron microscopy lab to study molecular structures half a million times smaller than a grain of rice.
Ablynx has granted a license to Eddingpharm to develop and commercialize its anti-RANKL Nanobody, ALX-0141, in China, Hong Kong, Macau and Taiwan.
Charles River Laboratories has acquired BRASS Pte Ltd, a company that manufactures biopharmaceutical and medical products.
The University of Melbourne and Procypra Therapeutics have agreed to develop therapy to treat Parkinson’s disease.
A six million dollar Australia-India partnership project will focus on improving processes involved in the production of dimethyl ether (DME), a clean-burning synthetic fuel.
Research institutes in Singapore and Korea will team up to promote joint research and collaboration in the field of sustainable chemicals.
Takeda has announced the results of a Phase 1/2 study of its norovirus vaccine candidate which was found to be well tolerated.
Hutchison MediPharma has entered into a collaboration with Eli Lilly to develop fruquintinib, a targeted oncology therapy against solid tumors.
Apollo Hospitals and Medtronic have announced a collaboration to bring an affordable and portable hemodialysis system to India.